AFP and viral hepatitis: When conducting a subgroup analysis of the viral hepatitis cohort, the number of AFP tests performed (HR = 0.96, 95% CI: 0.95–0.96), as well as receiving antiviral treatment, were identified as independent protective factors for developing HCC (Table 3).